How New GAD Treatment Gap Data At Definium Therapeutics (DFTX) Has Changed Its Investment Story

Summary

Definium Therapeutics has released new treatment gap data for generalized anxiety disorder that impacts its investment narrative. The article title indicates a data readout but specific details about outcomes, trial phases, or clinical results are not provided in the article excerpt.